Haque, A. K. M. Ashiqul
Dewerth, Alexander
Antony, Justin S. http://orcid.org/0000-0003-1241-2013
Riethmüller, Joachim
Schweizer, Georg R. http://orcid.org/0000-0001-7032-1000
Weinmann, Petra
Latifi, Ngadhnjim
Yasar, Hanzey
Pedemonte, Nicoletta http://orcid.org/0000-0002-5161-1720
Sondo, Elvira
Weidensee, Brian
Ralhan, Anjali
Laval, Julie
Schlegel, Patrick
Seitz, Christian
Loretz, Brigitta
Lehr, Claus-Michael
Handgretinger, Rupert
Kormann, Michael S. D. http://orcid.org/0000-0003-3492-0393
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (4258/2-1)
EC | European Research Council (637752)
Article History
Received: 31 May 2018
Accepted: 28 September 2018
First Online: 13 November 2018
Competing Interests
: M.S.D.K. holds a patent on RNA modification (EP2459231B1). M.S.D.K., A.H., A.D. and J.S.A., hold a European patent on delivery of cmRNA<sup>h<i>CFTR</i></sup> complexed with nanoparticles (17169561.2-1401).